bims-mikwok Biomed News
on Mitochondrial quality control
Issue of 2025–11–23
sixty-two papers selected by
Gavin McStay, Liverpool John Moores University



  1. Eur J Pharmacol. 2025 Nov 14. pii: S0014-2999(25)01130-6. [Epub ahead of print]1008 178376
      Heart failure (HF) remains a prevalent complication following myocardial infarction (MI), characterized by mitochondrial dysfunction and cardiomyocyte ferroptosis, which jointly contribute to myocardial remodeling and impaired cardiac function. The present study aims to evaluate the cardioprotective efficacy and underlying mechanisms of trimetazidine (TMZ), a clinically established anti-anginal agent, in alleviating post-MI HF regulation of mitochondrial quality control and ferroptosis inhibition. Utilizing an in vivo mouse model established by left coronary artery ligation, TMZ administration significantly improved cardiac function, delayed ventricular remodeling, and reduced myocardial infarct size. Concurrently, TMZ treatment significantly reduced myocardial oxidative stress, evidenced by elevated antioxidant enzyme levels (GSH and SOD), decreased malondialdehyde (MDA), and lower intracellular Fe2+ accumulation, along with upregulation of key anti-ferroptotic markers GPX4 and SLC7A11. Complementary in vitro experiments on oxygen-glucose deprivation (OGD)-injured HL-1 cardiomyocytes confirmed that TMZ preserved cellular viability in a dose-dependent manner by inhibiting ferroptosis. Furthermore, TMZ effectively restored mitochondrial membrane potential, improved mitochondrial morphology, promoted mitophagy by increasing PINK1/Parkin pathway activation, and corrected mitochondrial dynamics through upregulation of MFN1 and downregulation of DRP1. Notably, when the mitophagy inhibitor Mdivi-1 or PINK1 siRNA was used, the protective effect of TMZ was reversed by inhibition of mitophagy. This suggests that mitophagy activated through PINK1/Parkin signaling is essential for TMZ-mediated myocardial protection and ferroptosis suppression. Molecular docking further validated TMZ's potential direct interaction with PINK1. In conclusion, these findings demonstrate that TMZ ameliorates post-MI heart failure by orchestrating mitochondrial quality control through promotion of mitophagy and suppression of GPX4-dependent ferroptosis, offering novel mechanistic insight into its therapeutic potential in the management of ischemic heart disease.
    Keywords:  Ferroptosis; GPX4; Heart failure; Mitophagy; Myocardial infarction; PINK1/Parkin; Trimetazidine
    DOI:  https://doi.org/10.1016/j.ejphar.2025.178376
  2. J Biochem Mol Toxicol. 2025 Nov;39(11): e70607
      Parkinson's disease (PD) is the fastest growing neurodegenerative disorder worldwide. Available treatments are only symptomatic, urging the demand for new therapies. Ferroptosis is increasingly reported as a critical player in neurodegeneration. Meanwhile, ferroptosis is activated by impaired mitophagy under rigorous milieu of oxidative stress that disrupts mitochondrial homeostasis. However, the interplay between ferroptosis and mitophagy is not fully elucidated in PD. Carvedilol is a cardiovascular antioxidant, antiferroptotic drug with lipophilic nature that allows its passage via blood brain barrier. Moreover, its effect on modulating mitochondrial balance is emerging in multiple disorders. Therefore, This study aimed to explore the possible neuroprotective mechanistic effects of carvedilol on rotenone-induced PD rat model in context of ferroptosis-mitophagy interaction. Rotenone-induced toxicities were detected by Immunohistochemistry, ELISA, qPCR and western blot analysis techniques. Rotenone disrupted key players of ferroptosis-mitophagy axes. Nrf2, Glutathione peroxidase (GPX4), Catalase, PINK 1/PARKIN levels were drastically decreased. Acyl coA synthetase long chain (ACSL4), MDA and NF-κB levels were significantly increased. Contrarily, carvedilol preserved adequate Nrf2, GPX4, PINK1 and PARKIN levels and increased catalase. Furthermore, it downregulated ACSL4, reduced NF-κB and MDA levels to maintain normal mitophagy and inhibit ferroptosis. Carvedilol's protective effects extended to alleviate α-synuclein and upregulate tyrosine hydroxylase in the striata and substantia nigra leading to distinguished improvements of motor functions. To the best of our knowledge, this is the first study to highlight carvedilol's neuroprotective capacity against PD pathologies in terms of ferroptosis - mitophagy interaction as a novel therapeutic approach to tackle PD at earlier stages.
    Keywords:  Nrf2; PINK1; Parkinson's; carvedilol; ferroptosis; mitophagy
    DOI:  https://doi.org/10.1002/jbt.70607
  3. Exp Physiol. 2025 Nov 19.
      Skeletal muscle plays an important role in whole-body health, quality of life and regulation of metabolism. The maintenance of a healthy mitochondrial pool is imperative for the preservation of skeletal muscle quality and is mediated through mitochondrial quality control consisting of mitochondrial turnover mediated by a balance between organelle synthesis and degradation. The selective tagging and removal of dysfunctional mitochondria is essential for maintaining mitochondrial quality control and is termed mitophagy. The mechanisms of the initial stages of mitophagy involving the recognition and tagging of mitochondria within skeletal muscle are well established, but our understanding of the terminal step involving organelle degradation mediated via lysosomes is in its infancy. An assessment of the proteolytic functions to facilitate the removal and breakdown of dysfunctional mitochondria is crucial for our understanding of the mechanisms of mitophagy, which is essential for maintaining skeletal muscle health. The aim of this review is to address the current knowledge surrounding mitophagy and lysosomal function, alongside distinct physiological conditions, such as ageing, exercise and disuse, that have varying effects on mitophagy and lysosomal adaptations within skeletal muscle.
    Keywords:  Parkin; adaptation; lysosomes; mitophagy; skeletal muscle; transcription factor EB
    DOI:  https://doi.org/10.1113/EP093041
  4. Front Physiol. 2025 ;16 1664909
      Exercise-induced fatigue is closely associated with mitochondrial dysfunction, and mitophagy plays a critical role in maintaining mitochondrial homeostasis by clearing damaged mitochondria and reducing oxidative stress. This review systematically summarizes current evidence on the regulatory mechanisms of mitophagy in exercise-induced fatigue, particularly through pathways such as PINK1/Parkin, BNIP3/Nix, FUNDC1, and AMPK, and examines how natural compounds including sulforaphane, Rhodiola crenulata, ginseng, modulate these pathways to alleviate fatigue. These findings suggest the presence of mitophagy threshold in different models and highlight its potential as a therapeutic target for fatigue management. Ultimately, this review proposes novel strategies for developing natural anti-fatigue agents based on mitophagy regulation, while underscoring the need for further mechanistic studies in diverse physiological and pathological settings.
    Keywords:  exercise-induced fatigue; mitophagy; mitophagy pathways; natural compounds; therapeutic targets
    DOI:  https://doi.org/10.3389/fphys.2025.1664909
  5. Phytother Res. 2025 Nov 21.
      Alzheimer's disease (AD), a prevalent senile dementia, is characterized by the progressive decline in cognitive function, accumulation of tau tangles and Aβ plaques. Despite significant research efforts in the field of AD, effective therapeutic drugs for its prevention and treatment remain elusive. Consequently, a more comprehensive understanding of the molecular mechanisms underlying the pathological processes of AD is crucial for novel therapeutic strategies. Mitophagy, the selective degradation of mitochondria through autophagy, is an essential mechanism for maintaining mitochondrial homeostasis in terms of both quantity and quality. Mitophagy plays a crucial role in numerous cellular processes, including inflammation, differentiation, and apoptosis. Recent studies have increasingly demonstrated that mitophagy is extensively characterized in AD and may represent a novel therapeutic strategy for its treatment. Notably, a number of natural plant products (NPPs) have been demonstrated to modulate mitophagy and intervene in the pathological process of AD. For instance, NPPs such as urolithin A and β-asarone have been reported to enhance mitophagy by activating the PINK1/Parkin pathway, thereby alleviating Aβ-induced neurotoxicity. The distinctive multi-target properties and favorable safety profiles of NPPs endow them with significant research potential and developmental value, establishing them as a vital resource for novel drug discovery. This review explores the mechanistic hypotheses linking mitophagy to AD pathology and provides a systematic overview of recent advances in representative NPPs that regulate mitophagy to alleviate AD-related impairments, offering new perspectives for the development of therapeutic strategies against AD.
    Keywords:  Alzheimer's disease; Mitophagy; mitochondria; natural plant products
    DOI:  https://doi.org/10.1002/ptr.70131
  6. Hereditas. 2025 Nov 20. 162(1): 230
      Parkinson's disease (PD) is closely linked to mitochondrial dysfunction and mitophagy, a key mechanism in PD pathogenesis. However, no dedicated bibliometric analysis of mitophagy in PD exists. This study used data from the Web of Science Core Collection to map the global research landscape of mitophagy in PD. The analysis of 1,578 publications (2007-2024) identifies the United States as the most productive country. McGill University ranks as the top institution, and Nobutaka Hattori is the most prolific author. The journal Autophagy is the journal with the highest number of publications in this field. Core research themes included PINK1/Parkin, mitochondrial quality control, α-synuclein, neuroinflammation, and ferroptosis. The study provides insights into the current status of global collaboration and translational progress in this field. Future efforts should aim to further explore new pathways, enhance clinical translation, and promote collaborative partnerships to advance research and address challenges in the field.
    Keywords:  Bibliometric analysis; Mitophagy; PINK1/Parkin; Parkinson’s disease
    DOI:  https://doi.org/10.1186/s41065-025-00544-y
  7. Mol Neurobiol. 2025 Nov 19. 63(1): 69
      Mitophagy refers to selective mitochondrial autophagy to remove damaged mitochondria and plays a critical role in maintaining mitochondria homeostasis. Casein kinase 2α (CK2α) is involved in mitophagy regulation in dopaminergic neurons. Endoplasmic reticulum (ER) stress releases calcium into mitochondria, leading to mitochondrial dysfunction and contributing to various diseases. However, it is not clear whether CK2α regulates ER-mediated mitochondrial dysfunction and mitophagy in response to ER stress. Therefore, we investigated the effects of ER stress on mitophagy during rotenone-induced ER stress and mitochondrial damage in SH-SY5Y cells and elucidated the role of CK2α in this process. Rotenone increased the expression of P-PERK and P-IRE1α, thereby activating ER stress sensors. CK2α inhibition suppressed PERK and IRE1α activation and their downstream signaling components (eIF2α, ATF4, CHOP and XBP1s). Furthermore, CK2α inhibition enhanced PINK1/Parkin-mediated mitophagy by increasing PINK1 and Parkin translocation to mitochondria in addition to inducing LC3II expression. These results suggest that CK2α regulates PINK/Parkin-dependent mitophagy in rotenone-treated cells. Interestingly, treatment of cells with the PERK inhibitor GSK2606414 also resulted in increased PINK1/Parkin-mediated mitophagy. Moreover, CK2α inhibition reduced rotenone-induced apoptosis by modulating PERK signaling. These findings suggest that CK2α plays a key role in regulating the ER stress response and PERK-dependent PINK1/Parkin-mediated mitophagy in our rotenone-induced apoptosis model. This study highlights the therapeutic potential of CK2α signal regulation for treating diseases driven by ER stress and mitochondrial dysfunction, offering a promising avenue for future research.
    Keywords:  Casein kinase 2α; ER stress; Mitophagy; PERK/ATF4/CHOP pathway; PINK/Parkin; Rotenone
    DOI:  https://doi.org/10.1007/s12035-025-05441-z
  8. Environ Int. 2025 Nov 08. pii: S0160-4120(25)00661-0. [Epub ahead of print]206 109910
      Nickel nanoparticles (Ni NPs), increasingly utilized in environmental energy, electronics, and biomedical fields, have raised growing concern due to their emerging reproductive toxicity. Our prior investigations revealed that Ni NPs trigger oxidative stress and apoptosis in male germ cells, contributing to compromised fertility in rodent models. Given the central role of mitochondria in cellular homeostasis, and mitophagy in maintaining mitochondrial integrity, we hypothesized that mitochondrial stress may mediate Ni NPs-induced spermatocyte injury. In the present study, we employed GC-2 mouse spermatocyte cells to elucidate the role of PINK1/Parkin-mediated mitophagy in Ni NPs-induced reproductive toxicity. Ni NPs exposure (25-100 μg/mL) led to significant reductions in cell viability and mitochondrial membrane potential (MMP), along with increases in apoptosis, reactive oxygen species (ROS) accumulation, and ATP depletion. Western blot analyses demonstrated elevated expression of mitophagy- and apoptosis-related proteins including PINK1, Parkin, LC3BII, P62, BAX, Caspase9, and Caspase3, with concurrent downregulation of LC3BI and the anti-apoptotic protein BCL2. Pharmacological inhibition of mitophagy using cyclosporin A (CsA, 3 μM) partially restored mitochondrial function, suppressed apoptosis, and ameliorated overall cytotoxicity. Moreover, lentivirus-mediated knockdown of Pink1 further reversed Ni NPs-induced cellular damage by reducing ROS levels, recovering ATP production and MMP, and downregulating mitophagy and apoptosis-related markers. These findings identify aberrant mitophagy as a critical driver of Ni NPs-induced reproductive toxicity and highlight PINK1 as a potential molecular target for therapeutic intervention. This study offers novel mechanistic insights into Ni NPs-induced male reproductive damage, with implications for occupational health and nanoparticle safety assessment.
    Keywords:  Cyclosporin A; Germ cell; Metal nanoparticle; Mitochondrial dysfunction; PINK1/Parkin; Reproductive toxicology
    DOI:  https://doi.org/10.1016/j.envint.2025.109910
  9. Redox Rep. 2025 Dec;30(1): 2589569
       BACKGROUND: Mitochondrial dynamics are tightly coupled with cellular redox homeostasis; however, the underlying regulatory mechanisms remain poorly defined.
    METHODS: We constructed yeast mutants and evaluated mitochondrial function, morphology, and redox states using growth assays, fluorescence imaging, and flow cytometry. RNA sequencing, RIP assays, and RT-qPCR were applied to identify Ecm19p target genes.
    RESULTS: Deletion of ECM19 alone had no evident impact on mitochondrial morphology or respiratory function. In contrast, double deletion of ECM19 with the fusion gene FZO1 (ecm19D fzo1D) rescued mitochondrial function and morphology and reduced ROS and malondialdehyde levels relative to fzo1D. Conversely, combining ecm19D with fission genes MDV1 or CAF4 resulted in hyperfused mitochondria, dependent on the division factor Dnm1p. RNA-seq revealed that ecm19D upregulates redox processes, including catalase (CTA1) and thiol peroxidase (TSA2). RIP-PCR confirmed Ecm19p binds directly to CTA1 and TSA2 transcripts and reduces their mRNA stability. Under H₂O₂ stress, ecm19D cta1D and ecm19D tsa2D double mutants exhibited improved growth, elevated antioxidant capacity, and lower ROS and malondialdehyde than single mutants.
    CONCLUSION: Ecm19 collaborates with Mdv1 and Caf4 to promote mitochondrial fission and post-transcriptionally represses CTA1 and TSA2 expression to regulate cellular redox, thereby coordinating mitochondrial fission with redox homeostasis.
    Keywords:  CAF4; CTA1; ECM19; MDV1; Mitochondrial fission; Mitochondrial fusion; TSA2; cellular redox
    DOI:  https://doi.org/10.1080/13510002.2025.2589569
  10. Biochim Biophys Acta Mol Basis Dis. 2025 Nov 19. pii: S0925-4439(25)00456-9. [Epub ahead of print]1872(3): 168106
      Kidney stone disease (KSD) is one of the most common urological disorders, and oxalate-induced tubular epithelial cell injury plays a crucial role in stone-related renal damage. However, the mechanisms linking oxalate exposure to mitochondrial dysfunction remain unclear. Urolithin A (UA), a gut microbiota-derived metabolite of ellagitannins, is recognized for its antioxidant and mitophagy-promoting properties. This study investigated the renoprotective effects and mechanisms of UA in calcium oxalate (CaOx) crystal-induced renal injury. In mice, UA markedly reduced renal CaOx deposition, improved renal function, and alleviated kidney injury. Consistently, both in vivo and in vitro experiments demonstrated that UA restored oxalate-suppressed mitophagy while also alleviating oxidative stress, apoptosis, and mitochondrial dysfunction. Transcriptomic and molecular docking analyses identified phosphoenolpyruvate carboxykinase 1 (PCK1) as a downstream target of UA. UA restored PCK1 expression under oxalate stress both in vivo and in vitro, whereas pharmacological inhibition of PCK1 weakened the renal protective and mitophagy-promoting effects. Conversely, PCK1 overexpression enhanced mitophagy under high-oxalate conditions. These findings indicate that UA alleviates CaOx-induced renal injury by activating PCK1-dependent mitophagy and restoring mitochondrial homeostasis. Given its natural origin and favorable safety profile, UA represents a promising candidate for preventing or treating calcium oxalate-associated renal injury.
    Keywords:  Kidney stone disease; Mitophagy; PCK1; Urolithin A
    DOI:  https://doi.org/10.1016/j.bbadis.2025.168106
  11. Hum Cell. 2025 Nov 21. 39(1): 12
      Radioresistance of adenocarcinoma cells limits the efficiency of radiotherapy. In addition to the cell nucleus, ionizing radiation (IR) also induces damage to the mitochondria. Mitophagy, a selective degradation of impaired mitochondria via autophagy, has been found to respond to IR, but its role in the radiosensitivity of adenocarcinoma cells remains unclear. Using several different adenocarcinoma cell lines, we confirmed that exposing the adenocarcinoma cells to 5 Gy X-ray enhanced the expression of some mitophagy receptors and increased mitophagy activity. However, pharmacological inhibition of mitophagy by mdivi-1 did not significantly change the radiosensitivity of HCT116 and A549 cells. Similarly, molecular targeting inhibition of mitophagy by BNIP3L knockdown in HCT116 and A549 cells that showed significant IR-induced BNIP3L up-regulation did also not significantly affect the radiosensitivity of adenocarcinoma cells, although the IR-induced enhancement of mitophagy activity was effectively suppressed. According to our data, mitophagy is responsible to IR but plays a very limited role in the radiosensitivity of adenocarcinoma cells. Further in vivo studies are warranted to elucidate the radiosensitizing effect of targeting mitophagy on malignant tumors.
    Keywords:  Adenocarcinoma; Autophagy; BNIP3L; Mitophagy; Radiotherapy
    DOI:  https://doi.org/10.1007/s13577-025-01328-2
  12. J Hazard Mater. 2025 Nov 13. pii: S0304-3894(25)03406-5. [Epub ahead of print]500 140486
      Deoxynivalenol (DON), a prevalent mycotoxin contaminant in food and feed, poses severe threats to both human and animal health. However, the mechanisms underlying DON-induced hepatotoxicity remain unclear. In this research, mice and the immortalized normal mouse hepatocyte cell line (AML-12) were treated with DON at 0 -4.8 mg/kg (7 d) and 0 -6.4 μM (24 h), respectively. Our results indicated that DON induces overactivation of PINK1/Parkin-mediated mitophagy, leading to mitochondrial damage. This activation promotes apoptosis, oxidative stress, inflammation, and lipid metabolism disorder, as confirmed through the use of mitophagy inhibitors (Mdivi-1) and si-PINK1. Moreover, DON simultaneously suppresses the p62-Keap1-Nrf2 cytoprotective pathway, thereby compromising the cellular defense system and amplifying injury. Notably, p62 overexpression mitigates DON-induced liver injury through competitive binding to Keap1, promoting Nrf2 nuclear translocation. Overall, our findings reveal that DON induces liver injury by inhibiting the p62-Keap1-Nrf2 signaling pathway via overactivation of PINK1/Parkin-mediated mitophagy.
    Keywords:  AML-12 cells; Deoxynivalenol; Liver; Mice; Mitophagy; p62-Keap1-Nrf2 signaling pathway
    DOI:  https://doi.org/10.1016/j.jhazmat.2025.140486
  13. Zhongguo Zhen Jiu. 2025 Nov 12. 45(11): 1617-1626
       Objective: Based on the PTEN-induced hypothetical kinase 1 (PINK1)/Parkin pathway, the effect of acupuncture pretreatment on the expression of mitochondrial autophagy-related proteins in gastrocnemius muscle tissue of rats with exercise-induced muscle damage (EIMD) was observed, and the underlying mechanism of acupuncture pretreatment for the prevention and treatment of EIMD was explored.
    Methods: Of 88 SD male rats, aged 6 weeks, 8 rats were randomly selected as a blank group, and the remaining 80 rats were randomized into a model group and an acupuncture pretreatment group, with 40 rats in each group. Either the model group or the acupuncture pretreatment group was subdivided randomly into 5 subgroups with 8 rats in each one according to the time points of sample collection, 0 h, 12 h, 24 h, 48 h and 72 h after modeling. An intermittent downhill running centrifugal exercise was carried out on an animal experimental treadmill to establish the EIMD model in the model group and the acupuncture pretreatment group. The rats in the acupuncture pretreatment group received acupuncture at "Guanyuan" (CV6) and bilateral "Zusanli" (ST36), once a day for 20 min each time, for 7 consecutive days before EIMD model preparation. Transmission electron microscopy was used to observe the ultrastructure of gastrocnemius muscle tissue in each group. The contents of malondialdehyde (MDA), superoxide dismutase (SOD) and catalase (CAT) in serum were detected by ELISA. Western blot was used to detect the protein expression of PINK1, Parkin, sequestosome 1 (p62) and microtubule-associated protein light chain 3B (LC3B) in rat gastrocnemius muscle tissue. Real-time PCR was adopted to detect the mRNA expression of PINK1, Parkin, p62 and LC3B in rat gastrocnemius muscle tissue.
    Results: Compared with the blank group, the mitochondria of gastrocnemius muscles showed obvious swelling in the 0 h, 12 h, 24 h, and 48 h model subgroups , autophagosomes were formed in the 12 h and 24 h model subgroups, and the mitochondrial morphology returned to normal gradually in the 72 h model subgroup. The serum MDA contents of rats in 5 model subgroups increased (P<0.01, P<0.05). The contents of SOD and CAT in the subgroups of 0 h, 12 h, 24 h and 48 h decreased (P<0.05, P<0.01). The protein and mRNA expression levels of PINK1, Parkin and LC3B in gastrocnemius muscle tissue of rats in 0 h, 12 h and 24 h subgroups were elevated (P<0.01); and the protein and mRNA expression levels of p62 in the 0 h, 12 h, 24 h and 48 h subgroups were reduced (P<0.01, P<0.05). Compared with the model subgroup at the same time point, the myofibril damage and the degree of mitochondrial swelling were mild in each acupuncture pretreatment subgroup, and the numbers of autophagosomes were fewer. The contents of MDA in the acupuncture pretreatment subgroups decreased at 0 h, 12 h, 24 h, and 48 h (P<0.05, P<0.01). The contents of SOD and CAT in the 12 h acupuncture pretreatment subgroup increased (P<0.05, P<0.01). The protein and mRNA expression levels of PINK1 and Parkin in the 0 h, 12 h, and 24 h acupuncture pretreatment subgroups decreased (P<0.01, P<0.05). The protein and mRNA expression levels of LC3B in the 12 h acupuncture pretreatment subgroup decreased (P<0.01), and that of p62 in the 0 h and 24 h acupuncture pretreatment subgroups increased (P<0.01, P<0.05).
    Conclusion: The intermittent downhill running centrifugal exercise induces the excessive mitochondrial autophagy. Acupuncture pretreatment may attenuate EIMD, and the underlying mechanism is related to the regulation of PINK1/Parkin signaling pathway expression, reducing oxidative stress damage in skeletal muscle cells, and inhibiting mitochondrial autophagy overactivation.
    Keywords:  PINK1/Parkin pathway; acupuncture pretreatment; exercise-induced muscle damage; mitochondrial autophagy; oxidative stress
    DOI:  https://doi.org/10.13703/j.0255-2930.20240920-k0002
  14. FEBS Open Bio. 2025 Nov 20.
      The sirtuin SIRT4 has been implicated in the control of autophagy and mitochondrial quality control via mitophagy. However, the role of SIRT4 in regulating autophagy/mitophagy induced by different stressors is unclear. Here, we show that cells expressing SIRT4(H161Y), a catalytically inactive, dominant-negative mutant of SIRT4, fail to upregulate LC3B-II. These cells also exhibit a reduced autophagic flux upon treatment with different inducers of mitophagy/autophagy, that is, CoCl2-triggered pseudohypoxia, CCCP (carbonyl cyanide 3-chlorophenylhydrazone)/oligomycin-mediated respiratory chain inhibition, or rapamycin treatment. Interestingly, SIRT4(H161Y) expression upregulated protein levels of HDAC6, which is involved in mitochondrial trafficking and autophagosome-lysosome fusion, and inhibited the conversion of OPA1-L to OPA1-S, which is associated with increased mitochondrial fusion and decreased mitophagy. Both HDAC6 and OPA1 are SIRT4 interactors. However, the pharmacological inhibition of HDAC6 using Tubacin or of OPA1 using MYLS22 did not restore the stress-induced upregulation of LC3B-II levels upon autophagy/mitophagy treatment in SIRT4(H161Y)-expressing cells. Remarkably, inhibition of autophagosome-lysosome fusion and thus disruption of late autophagic flux by BafA1 treatment also failed to restore LC3B-II levels upon autophagy/mitophagy treatment, suggesting an inhibitory effect of SIRT4(H161Y) on the initiation/early phase of autophagy. Consistent with this, we demonstrate that SIRT4(H161Y) promotes the phosphorylation of ULK1 at S638 and S758 (mTORC1 targets), both of which mediate an important inhibitory regulation of autophagy initiation. Thus, our data suggest a positive regulatory function of SIRT4 in the ULK1-dependent early regulation/initiation of stress-induced autophagic flux, presumably via modulation of AMPK/mTORC1 signaling.
    Keywords:  HDAC6; LC3; OPA1; SIRT4; ULK1; autophagy
    DOI:  https://doi.org/10.1002/2211-5463.70164
  15. Redox Biol. 2025 Nov 11. pii: S2213-2317(25)00431-8. [Epub ahead of print]88 103918
      N6-methyladenosine (m6A) RNA methylation, primarily mediated by methyltransferase-like 3 (METTL3), has emerged as a redox-sensitive epitranscriptomic switch in atherosclerosis (AS). Oxidative stress (OS) remodels the vascular transcriptome via m6A reprogramming, driving endothelial dysfunction, vascular smooth muscle cell (VSMC) phenotypic transition, and macrophage inflammatory activation. Reactive oxygen species directly influence METTL3 expression and activity, while METTL3 reciprocally modulates oxidative stress by regulating antioxidant defenses, ROS-scavenging enzymes, and redox homeostasis. Mechanistically, METTL3 promotes mitochondrial fission by enhancing Drp1 translation and suppresses mitochondrial biogenesis via destabilizing PGC-1α transcripts, converging to impair redox resilience and amplify inflammation. Inhibition of METTL3 alleviates intimal hyperplasia, restores contractile phenotypes, and may synergize with antioxidant therapy, mitochondrial quality control reinforcement, or pyroptosis suppression. Beyond METTL3, METTL4-mediated mitochondrial DNA 6 mA methylation also contributes to AS, with selective antagonists providing vascular protection. Natural products such as tanshinone and quercetin modulate m6A pathways, offering molecularly defined yet culturally rooted interventions. Deciphering the bidirectional crosstalk between ROS and epitranscriptomic regulation will guide precision therapeutics that bridge oxidative biology, RNA regulation, and translational cardiovascular medicine.
    Keywords:  Atherosclerosis; METTL3; Mitochondrial quality control; Pyroptosis; Reactive oxygen species; m(6)A RNA methylation
    DOI:  https://doi.org/10.1016/j.redox.2025.103918
  16. EMBO J. 2025 Nov 20.
      Damaged mitochondria can be cleared from the cell by mitophagy, using a pathway formed by the recessive Parkinson's disease genes PINK1 and Parkin. Whether the pathway senses diverse forms of mitochondrial damage via a common mechanism, however, remains uncertain. Here, using a novel Parkin reporter in genome-wide screens, we identified that diverse forms of mitochondrial damage converge on loss of mitochondrial membrane potential (MMP) to activate PINK1. Loss of MMP, but not the presequence translocase-associated import motor (PAM), blocked progression of PINK1 import through the translocase of the inner membrane (TIM23), causing it to remain bound to the translocase of the outer membrane (TOM). Ablation of TIM23 was sufficient to arrest PINK1 within TOM, irrespective of MMP. Meanwhile, TOM (including subunit TOMM5) was required for PINK1 retention on the mitochondrial surface. The energy state outside of the mitochondria further modulated the pathway by controlling the rate of new PINK1 synthesis. Together, our findings point to a convergent mechanism of PINK1-Parkin activation by mitochondrial damage: loss of MMP stalls PINK1 import during its transfer from TOM to TIM23.
    Keywords:  Autophagy; Glycolysis; Parkinson’s Disease; Unfolded Protein Response
    DOI:  https://doi.org/10.1038/s44318-025-00604-z
  17. Mol Biol Cell. 2025 Nov 19. mbcE25050235
      The maintenance of healthy mitochondria is essential to neuronal homeostasis. Mitophagy is a critical mechanism that degrades damaged mitochondria, and disruption of this process is associated with neurodegenerative disease. Previous work has shown that mammalian optineurin (OPTN), a gene mutated in familial forms of amyotrophic lateral sclerosis (ALS) and glaucoma, is an adaptor to recruit autophagy machinery to mitochondria for ubiquitin-dependent mitophagy in cultured cells. However, OPTN's role in neuronal mitophagy in vivo remains largely unknown. Here, we demonstrate the Drosophila autophagy adaptor gene Kenny, a homolog of OPTN, mediates the recruitment of the phagophore to mitochondria undergoing ubiquitin-dependent mitophagy. We find that Kenny colocalizes with ubiquitinated mitochondria targeted for autophagic degradation in larval motoneurons, and is concentrated on the mitochondrial surface in areas opposed to the phagophore. Removal of Kenny in conditions of induced mitophagy eliminates the recruitment of the phagophore to ubiquitinated mitochondria and decreases mitophagic flux. In basal conditions, loss of Kenny causes accumulation of ubiquitinated mitochondria in neurons, indicative of stalled mitophagy. These phenotypes were reproduced in Kenny mutants ablating the LC3-interacting region domain. Overall, this work establishes Kenny as a functional homolog of OPTN in flies, and a mediator of neuronal mitophagy in vivo.
    DOI:  https://doi.org/10.1091/mbc.E25-05-0235
  18. Chem Biol Interact. 2025 Nov 19. pii: S0009-2797(25)00474-0. [Epub ahead of print] 111844
      T-2 toxin, the most toxic type A mycotoxin, induces cardiotoxicity and impairs cardiac function. Herein, we investigated the regulatory role of mitophagy in T-2 toxin-induced myocardial injury. Using the Comparative Toxicogenomics Database, we identified 288 rat genes associated with T-2 toxin-induced myocardial injury. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes enrichment analyses revealed that mitophagy was significantly associated with myocardial injury. Protein-protein interaction network analysis revealed HIF-1α as the core regulatory gene. Rats were exposed to T-2 toxin and assigned to control, low-dose (100 ng/g·bw/day), and high-dose (200 ng/g·bw/day) groups. H9C2 cardiomyocytes were divided into control, low-dose (3 ng/mL), medium-dose (6 ng/mL), and high-dose (12 ng/mL) groups. High-dose T-2 toxin exposure caused significant myocardial damage, increased lactate dehydrogenase and creatine kinase-myocardial band levels, elevated reactive oxygen species (ROS) accumulation, and upregulated HIF-1α expression in the nucleus. Flow cytometry showed that T-2 toxin significantly decreased mitochondrial membrane potential. Transmission electron microscopy revealed mitochondrial swelling, vacuolation, and cristae disruption. Molecular docking and immunofluorescence confirmed direct binding between BNIP3L and LC3. T-2 toxin significantly upregulated HIF-1α, BNIP3L, and LC3 mRNA and protein levels, promoted LC3-I to LC3-II conversion, and suppressed P62 expression in tissues and cells. Immunohistochemistry further confirmed these protein expression trends. Myocardial injury was ameliorated by 2-ME2 by suppressing HIF-1α accumulation and BNIP3L-mediated mitophagy. In summary, T-2 toxin-induced ROS accumulation activated HIF-1α in cardiomyocytes, which regulated BNIP3L-LC3 binding, mediated mitophagy, and ultimately caused myocardial injury.
    Keywords:  Mitophagy; Myocardial injury; T-2 toxin
    DOI:  https://doi.org/10.1016/j.cbi.2025.111844
  19. Am J Chin Med. 2025 Nov 14. 1-37
      Malignant tumors remain a leading cause of global mortality and pose significant public health challenges. However, Traditional Chinese Medicine (TCM) and its natural products offer unique therapeutic potential in oncology which may help to address these challenges. Mitophagy, a selective form of autophagy, is a key regulator of mitochondrial quality, metabolic balance, and programmed cell death, and has dual roles in tumor initiation, progression, and therapeutic responses. The canonical PINK1/Parkin and receptor-mediated BNIP3, NIX, and FUNDC1 pathways coordinate both the removal of damaged mitochondria and adaptation to stress to thus influence tumor cell survival, proliferation, metastasis, and chemoresistance. This review systematically summarizes the mitophagy-related molecular mechanisms present in tumors, and highlights the multifaceted anticancer effects exerted by TCM via mitophagy. TCM exerts chemo-preventive effects on precancerous lesions, induces apoptosis, ferroptosis, and other forms of programmed cell death, reprograms tumor metabolism, and modulates inflammatory signaling, immune cell function, and immunogenic cell death to thereby collectively reshape the tumor immune microenvironment. Beyond its antitumor activities, TCM alleviates cancer-related fatigue through mitophagy regulation in the skeletal muscle. Moreover, combination therapies involving mitophagy modulators enhance TCM efficacy. Further studies which integrate single-cell omics, spatial metabolomics, and functional imaging are needed in order to define context-specific mitophagy regulation, optimize combination strategies, establish reliable biomarkers, and thus position TCM as a promising approach for personalized and integrative cancer therapy.
    Keywords:  Cancer; Cancer-Related Fatigue; Mitophagy; Traditional Chinese Medicine
    DOI:  https://doi.org/10.1142/S0192415X25500879
  20. Front Med (Lausanne). 2025 ;12 1686190
      The primary pathological features of osteoarthritis (OA) involve articular cartilage degradation and structural damage, coupled with osteophyte formation and inflammatory responses. As aging populations expand, the prevalence of knee osteoarthritis has risen substantially, severely compromising patients' quality of life. Current therapeutic strategies for knee osteoarthritis remain limited in clinical efficacy, creating an urgent need for novel treatments that are both effective and safe. Chinese herbal medicine monomers have demonstrated significant potential in OA management, offering multi-pathway therapeutic effects, multi-target modulation, and favorable safety profiles. However, its underlying mechanisms require further elucidation. Mitophagy, a selective mitochondrial quality control mechanism that eliminates reactive oxygen species-damaged organelles, plays a crucial role in maintaining chondrocyte homeostasis and function. Emerging evidence highlights the regulatory significance of mitophagy in OA progression, presenting novel therapeutic perspectives. This review comprehensively analyzes the molecular mechanisms and physiological roles of the oxidative stress-mitophagy axis in knee osteoarthritis pathogenesis, while summarizing recent advances in herbal monomer-mediated regulation of this pathway. Future research directions are proposed to facilitate the systematic exploration and clinical translation of Chinese herbal medicine in OA therapeutics.
    Keywords:  Chinese herbal medicine monomers; mitochondrion; mitophagy; osteoarthritis; reactive oxygen species
    DOI:  https://doi.org/10.3389/fmed.2025.1686190
  21. Autophagy. 2025 Nov 19.
      Mitochondrial reactive oxygen species (mtROS) are typically viewed as harmful byproducts of stress. However, our recent study establishes their fundamental role as essential signaling molecules that activate a protective adaptive response. We discovered that mtROS serve as the specific trigger to activate the ATM-CHEK2/CHK2 DNA damage response pathway, which in turn coordinates the key steps of PINK1-PRKN/Parkin-dependent mitophagy. Upon activation by mtROS, CHEK2 phosphorylates ATAD3A to initiate PINK1 import arrest, OPTN to enhance cargo recognition, and BECN1 (beclin 1) to promote autophagosome formation. This work reveals a novel mtROS-driven signaling cascade, expanding the function of the ATM-CHEK2 pathway beyond the nucleus and positioning it as a central integrator of cellular homeostasis by responding to both genomic and mitochondrial stress.
    Keywords:  Dna damage response pathway; OPTN; PINK1; mitophagy; mtROS
    DOI:  https://doi.org/10.1080/15548627.2025.2592883
  22. Clin Rheumatol. 2025 Nov 20.
       OBJECTIVES: Premature T cell aging, marked by telomere shortening and cell cycle arrest, plays a key role in the pathogenesis of rheumatoid arthritis (RA). Growing evidence suggests that high glucose-induced metabolic dysfunction critically regulates both cellular aging and RA progression. This study explores how high glucose exacerbates T cell aging, providing novel insights into the mechanisms underlying RA development.
    METHODS: CD4+ T cells isolated from RA patients and healthy controls, along with HC-derived CD4+ T cells cultured in either low- or high-glucose conditions, were analyzed for aging markers including telomere length and cell cycle regulatory proteins to evaluate glucose-dependent effects. Cellular metabolism was characterized through: (1) glucose uptake (2-NBDG assay), (2) mitochondrial respiration (oxygen consumption rate analysis), and (3) mitophagy activity (DRP1/PINK1/parkin protein levels by immunoblotting). Mechanistic studies employed both pharmacological interventions (2-DG for glycolysis inhibition, succinyl phosphonate for OGDH inhibition, Mdivi-1 for DRP1 blockade) and genetic manipulation (DRP1 knockdown and overexpression) to delineate the roles of glucose metabolism and DRP1-mediated mitophagy in T cell aging.
    RESULTS: RA-derived CD4+ T cells exhibited increased glucose uptake and mitochondrial dysfunction. Enhanced mitophagy accelerated T-cell aging in RA. Mechanistically, high glucose promoted succinate accumulation, a key TCA cycle metabolite, leading to succinylation of Zinc Finger Protein 76 (ZNF76), a DRP1 transcription factor. This activated ZNF76, upregulating DRP1-mediated mitophagy and driving T-cell aging. Targeting glucose uptake and mitophagy may thus reverse T-cell dysfunction and ameliorate RA severity.
    CONCLUSION: Elevated mitophagy induced by high glucose represents a cell-autonomous mechanism driving premature T cell aging in RA, presenting a novel therapeutic avenue for disease management. Key Points • Dysregulated glucose metabolism is a key driver of T cell aging and RA pathogenesis. • High glucose exposure triggers metabolic reprogramming, leading to succinate accumulation. • Accumulated succinate induces ZNF76 succinylation and enhances DRP1-dependent mitophagy-a phenotype consistently observed in CD4+ T cells from RA patients. • DRP1-dependent mitophagy drives T cell aging in RA.
    Keywords:  CD4+ T cells; DRP1; Rheumatoid Arthritis; Succinylation
    DOI:  https://doi.org/10.1007/s10067-025-07815-z
  23. Ann Clin Lab Sci. 2025 Sep;55(5): 682-693
       OBJECTIVE: This study unveils how obacunone (OB) mitigates ulcerative colitis (UC)-induced colonic epithelial cell injury by activating mitophagy via the poly(ADP-ribose) polymerase 1 (PARP1)/sirtuin 1 (SIRT1) signaling pathway.
    METHODS: Bioinformatics analyses and network pharmacology were utilized to identify potential OB-related targets in UC, after which Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses were conducted. Core targets were identified via Cytoscape network modeling and machine learning algorithms. The dextran sulfate sodium (DSS)-treated human intestinal epithelium cell line (NCM460) served as an in vitro model of UC. Prior to DSS treatment, cells were pre-incubated with OB and/or the mitophagy inhibitor Mdivi-1. Furthermore, PARP1-overexpressing NCM460 cells were co-treated with OB and DSS. Cell viability and apoptosis, as well as mitochondrial reactive oxygen species (mtROS) levels were measured using the CCK-8 assay, flow cytometry, and MitoSOX Red staining, respectively. The expression of PARP1, SIRT1, PTEN-induced putative kinase 1 (PINK1), Parkin, and microtubule-associated protein 1A/1B-light chain 3 (LC3) was evaluated through Western blot analysis.
    RESULTS: 145 potential targets implicated in bacterial component recognition, oxidative stress response, and inflammation/apoptosis regulation were identified after bioinformatics and network pharmacology analyses. Machine learning algorithms further refined these to five core targets (PARP1, HIF1A, PTGS2, ITGB1, and HSP90AB1), all of which demonstrated strong binding affinity with OB. In DSS-treated NCM460 cells, OB significantly improved cell viability, while reducing apoptosis and mtROS production. Mechanistic studies revealed that OB suppressed PARP1 expression while upregulating SIRT1, PINK1, Parkin, and LC3II. Notably, the protective effects of OB were abrogated by Mdivi-1 treatment or PARP1 overexpression, both of which decreased cell viability, increased apoptosis and mtROS levels, and downregulated PINK1, Parkin, and LC3II expression.
    CONCLUSION: OB attenuates UC-associated epithelial damage through PARP1/SIRT1-dependent mitophagy activation.
    Keywords:  Obacunone; PARP1/SIRT1; mitophagy; ulcerative colitis
  24. Mol Neurobiol. 2025 Nov 19. 63(1): 76
      Vascular cognitive impairment (VCI), a consequence of chronic cerebral ischemia, is characterized by an insidious onset and challenging diagnosis. Ferroptosis is a recently identified form of iron-dependent, lipid peroxidation-mediated cell death, and is closely associated with mitochondrial function. While ferroptosis has been implicated in several neurological diseases, its role in VCI remains poorly understood. In this study, we investigated how modulating ferroptosis (ferrostatin-1), mitochondrial fission (Mdivi-1), and Nrf-2 (ML385) affected HT22 cells subjected to oxygen-glucose deprivation (OGD) via the measurement of ROS and caspase-3 levels. A rat model of VCI, induced by bilateral common carotid artery occlusion, was used to assess the effects of Mdivi-1 and ML385 on cognitive function (Morris water maze), neuronal apoptosis, ferroptosis, and the expression of mitochondrial fission-/fusion-related proteins (immunofluorescence and western blotting). Neural damage in the hippocampus and cortex was evaluated via hematoxylin and eosin staining. Mitochondrial ultrastructure and ROS levels were examined by transmission electron microscopy and dihydroethidium staining, respectively. Molecular docking was used to analyze Mdivi-1/Nrf-2 interaction. In vitro, ferrostatin-1 and Mdivi-1 reduced OGD-induced ROS accumulation and apoptosis, whereas ML385 exacerbated these effects. In vivo, Mdivi-1 improved VCI by reducing cortical injury, hippocampal apoptosis, and mitochondrial ultrastructural damage. This was achieved by inhibiting DRP1-dependent mitochondrial fission, promoting MFN1/2 expression, and activating Nrf-2/HO-1/GPX4 signaling, thereby suppressing oxidative stress and ferroptosis. However, ML385 reversed these effects. Molecular docking studies supported a direct interaction between Mdivi-1 and Nrf-2. Thus, targeting DRP1-mediated mitochondrial fission and Nrf-2/HO-1/GPX4-mediated ferroptosis offers a promising therapeutic strategy for VCI.
    Keywords:  Ferroptosis; Mitochondrial fission; Nrf-2/HO-1/GPX4 signaling; Oxidative stress; Vascular cognitive impairment
    DOI:  https://doi.org/10.1007/s12035-025-05484-2
  25. bioRxiv. 2025 Oct 01. pii: 2025.09.29.679307. [Epub ahead of print]
      To maintain a healthy mitochondrial population in a long-lived cell like a neuron, mitochondria must be continuously replenished through the process of mitochondrial biogenesis. Because the majority of mitochondrial proteins are nuclear encoded, mitochondrial biogenesis requires nuclear sensing of mitochondrial population health and function. This can be a challenge in a large, compartmentalized cell like a neuron in which a large portion of the mitochondrial population is in neuronal compartments far from the nucleus. Using in vivo assessments of mitochondrial biogenesis in zebrafish neurons, we determined that mitochondrial transport between distal axonal compartments and the cell body is required for sustained mitochondrial biogenesis. Estrogen-related receptor transcriptional activation links transport with mitochondrial gene expression. Together, our data support a role for retrograde feedback between axonal mitochondria and the nucleus for regulation of mitochondrial biogenesis in neurons.
    DOI:  https://doi.org/10.1101/2025.09.29.679307
  26. Front Physiol. 2025 ;16 1673181
       Background: Pulmonary arterial hypertension (PAH) is a progressive disorder characterized by pulmonary vascular remodeling and mitochondrial dysfunction. Recent studies have implicated impaired mitophagy in the pathogenesis of PAH; however, the underlying mechanisms and associated biomarkers remain insufficiently defined. This study used an integrative approach, incorporating bulk transcriptomic profiling, single-cell RNA sequencing (scRNA-seq), machine learning algorithms, and experimental validation to explore the relationship between mitophagy and PAH.
    Methods: Differentially expressed genes were extracted from publicly available microarray datasets and intersected with mitophagy-related genes curated from the MitoCarta 3.0 database. Weighted gene co-expression network analysis, along with five distinct machine learning models, identified five candidate mitophagy-associated biomarkers: RRAS, BECN1, MFN1, HIF1A, and TAX1BP1. These genes demonstrated high diagnostic performance (area under the curve >0.9) across both training and validation cohorts. Immune cell deconvolution analysis indicated a marked increase in M1 macrophage infiltration in lung tissue from individuals with PAH. The scRNA-seq further localized the expression of these biomarkers predominantly to monocyte/macrophage populations and indicated distinct pseudotemporal expression trajectories during macrophage differentiation. Expression and co-localization of the identified biomarkers with autophagy and inflammation markers were subsequently validated using quantitative PCR, western blotting, and immunofluorescence in a monocrotaline-induced PAH rat model.
    Results and Conclusion: The findings underscore the involvement of mitophagy in the pathobiology of PAH and identify five macrophage-associated biomarkers with strong diagnostic potential. These results may inform future strategies aimed at early detection and targeted therapeutic interventions in PAH.
    Keywords:  biomarkers; macrophages; mitophagy; pulmonary arterial hypertension; single-cell RNA sequencing
    DOI:  https://doi.org/10.3389/fphys.2025.1673181
  27. J Cell Biol. 2026 Jan 05. pii: e202503028. [Epub ahead of print]225(1):
      Mitophagy transports mitochondria to lysosomes for degradation to maintain energy homeostasis, inflammation, and immunity. Here, we identify CipB, a type III secretion system (T3SS) effector from Chromobacterium violaceum, as a novel exogenous mitophagy receptor. CipB targets mitochondria by the mitochondrial protein TUFM and recruits autophagosomes via its LC3-interacting region (LIR) motifs. This process initiates the mitophagy-TFEB axis, triggering TFEB nuclear translocation and suppression of proinflammatory cytokines, thereby promoting bacterial survival and pathogenesis. CipB represents a conserved family of T3SS effectors employed by diverse pathogens to manipulate host mitophagy. Using a mouse model, CipB's mitophagy receptor function is critical for C. violaceum colonization in the liver and spleen, underscoring its role in bacterial virulence. This study reveals a novel mechanism by which bacterial pathogens exploit host mitophagy to suppress immune responses, defining CipB as a paradigm for exogenous mitophagy receptors. These findings advance our understanding of pathogen-host interactions and highlight the mitophagy-TFEB axis as a potential signaling pathway against bacterial infection.
    DOI:  https://doi.org/10.1083/jcb.202503028
  28. Biochem Pharmacol. 2025 Nov 14. pii: S0006-2952(25)00814-7. [Epub ahead of print]243(Pt 2): 117549
      Triple-negative breast cancer (TNBC) lacks targeted therapies and effective treatments, emphasizing the need for new drugs. Abnormal mitochondrial fission-fusion dynamics are closely linked to poor prognosis and invasiveness in TNBC. Icariin (ICA), a flavonoid glycoside, exhibits anti-cancer effects by inhibiting cell proliferation, metastasis, autophagy induction, and apoptosis through diverse pathways. This study explores how ICA affects mitochondrial fission-fusion in TNBC cells and its specific mechanism behind its anti-tumor effect. Experimental results show that; ICA can inhibit cell autophagy by suppressing the Dynamin-related protein 1 (DRP1)-mediated mitochondrial fission pathway in TNBC and promote cell apoptosis through excessive accumulation of reactive oxygen species (ROS). To sum up, our results further elucidate the anticancer mechanism of ICA in TNBC and provide potential targets for the development of new drugs.
    Keywords:  Apoptosis; Autophagy; Icariin; Mitochondrial fission and fusion; ROS; Triple-negative breast cancer
    DOI:  https://doi.org/10.1016/j.bcp.2025.117549
  29. Sci Rep. 2025 Nov 20. 15(1): 41010
      Mitochondrial autophagy (mitophagy) in macrophages is crucial yet poorly understood within the lung adenocarcinoma (LUAD) tumor microenvironment. This study aimed to identify key macrophage mitophagy-related genes and develop a robust prognostic model for LUAD patients. By integrating single-cell transcriptomics with machine learning algorithms, including LASSO, SVM, and random forest, we identified TUBB6 and CAT as core prognostic genes. A novel risk model based on these genes (RiskScore = 0.225 × TUBB6 - 0.19 × CAT) was constructed and validated, demonstrating that patients in the high-risk group had significantly shorter overall survival (P < 0.001). The high-risk score also correlated with an altered immune microenvironment and increased sensitivity to chemotherapies like cisplatin and gemcitabine. Furthermore, in vitro experiments confirmed that macrophage-specific overexpression of TUBB6 significantly enhanced LUAD cell proliferation, migration, and invasion through secreted factors. Our findings establish a reliable, macrophage mitophagy-based prognostic model and highlight TUBB6 and CAT as novel biomarkers and potential therapeutic targets, offering new avenues for precision medicine in LUAD.
    Keywords:  Drug sensitivity; Lung adenocarcinoma; Machine learning; Macrophages; Mitophagy; Single-cell transcriptomics
    DOI:  https://doi.org/10.1038/s41598-025-24769-z
  30. Cell Death Dis. 2025 Nov 17. 16(1): 832
      Endothelial dysfunction contributes to the development of cardiovascular disease in patients with diabetes mellitus, and current strategies remain inadequate. Although mesenchymal stromal cells (MSCs) have shown beneficial effects in experimental models of diabetes, underlying mechanisms remain elusive. Here, using a human umbilical vein endothelial cells (HUVECs) treated with high concentration of glucose (HG) and a mouse model of type 2 diabetes (db/db mice), we demonstrate MSCs could alleviate hyperglycemia-induced endothelial injury by preventing aberrant mitochondrial morphology. Mechanistically, stanniocalcin-1(STC1) was identified to be an important paracrine factor secreted by MSCs, which restrains hyperactivation of ERK1/2, thus preventing Drp1-mediated excessive mitochondrial fission, and thereby protecting against hyperglycemia-induced oxidative injury, endothelial inflammation and mitochondrial apoptotic pathway, consequently protecting endothelial dysfunction. Hence, this study reveals that MSCs-derived STC1 regulates mitochondrial dynamics remodeling through inhibiting ERK1/2-Drp1 axis and provide a therapeutic target in diabetic vasculopathy and regenerative medicine.
    DOI:  https://doi.org/10.1038/s41419-025-08175-x
  31. Cell Death Discov. 2025 Nov 17. 11(1): 536
      Spinal cord ischemia-reperfusion injury (SCIRI) is a severe secondary complication of trauma, spinal cord decompression, and thoracoabdominal aortic surgery. Ferroptosis, a regulated cell death pathway characterized by iron-dependent accumulation of lethal reactive oxygen species and lipid peroxidation, has been implicated in various pathological conditions. However, its precise role and molecular mechanisms in SCIRI remain unclear. In this study, we demonstrated that ferroptosis contributes to the pathophysiology of SCIRI. Heme oxygenase 1 (HMOX1) was upregulated in both SCIRI rats and neuronal cells subjected to hypoxia-reoxygenation. Genetic knockdown of HMOX1 in vivo and in vitro markedly attenuated neuronal ferroptosis, improving neurological function, whereas HMOX1 overexpression reproduced characteristic ferroptotic events in vitro. HMOX1 upregulation appeared to stimulate autophagic flux and induce substantial mitophagy, suggesting a potential mechanistic link between HMOX1 and ferroptosis promotion. Mitophagy reduction diminished HMOX1-mediated ferroptosis, whereas mitophagy induction acted synergistically with HMOX1. HMOX1 physically interacted with BNIP3, triggering excessive mitophagy and subsequent ferroptosis. In this study, we establish ferroptosis as a critical contributor to SCIRI pathogenesis and identify HMOX1 as a central regulator of this process. Furthermore, mitophagy-dependent ferroptosis, mediated by the HMOX1-BNIP3 axis, emerges as a promising therapeutic target for SCIRI intervention.
    DOI:  https://doi.org/10.1038/s41420-025-02831-z
  32. J Interferon Cytokine Res. 2025 Nov 17.
      This study was conducted to investigate the protective effect of platelet-rich plasma-derived exosomes (PRP-Exos) in diabetic wound healing, as well as the involved molecular mechanism. Exosomes collected from PRP were extracted and identified, then the promoting effect on diabetic wound healing was tested in high glucose and lipopolysaccharide (HL)-induced RAW264.7 cells and excisional wound models constructed in streptozotocin-induced diabetic SD rats. PRP-Exos showed the best capacity for accelerating wound healing in the diabetic rat model. Cell proliferation of RAW264.7 cells was effectively facilitated after HL treatment, while PRP-Exos implemented could obviously eliminate the HL effect on RAW264.7 cells. The protein expression levels of PINK1, parkin, and LC3I/LC3II were both obviously diminished, and the expression of kininogen-1 (KNG1) was obviously increased in HL-induced RAW264.7 cells, while the opposite results were observed after PRP-Exos treatment. HL treatment could remarkably suppress the protein expression levels of p-PI3K/PI3K and p-AKT/AKT in RAW264.7 cells, while PRP-Exos administration could reverse this trend. Interestingly, KNG1 upregulation could effectively reverse the effect of PRP-Exos on the tumor necrosis factor-alpha and high mobility histone 1 levels, protein expression of p-PI3K/PI3K and p-AKT/AKT, and mitophagy-related markers in HL-induced RAW264.7 cells. In conclusion, PRP-Exos facilitated macrophage mitophagy in diabetic wound healing by targeting KNG1 via PI3K-AKT pathway.
    Keywords:  KNG1; PI3K–AKT; diabetic wound healing; exosomes derived from platelet-rich plasma; macrophage mitophagy
    DOI:  https://doi.org/10.1177/10799907251391527
  33. Tissue Cell. 2025 Nov 15. pii: S0040-8166(25)00509-9. [Epub ahead of print]98 103227
      One major cause of discomfort in the lower back pain (LBP) that significantly burdens both individuals and society is intervertebral disc degeneration (IVDD). The degenerative disease IVDD is typified by the death of nucleus pulposus cells (NPC) and the decomposition of extracellular matrix brought on by a number of factors. Current pharmacologic and surgical treatments are limited for the palliation and treatment of IVDD, and further exploration of the pathophysiologic mechanisms of IVDD is needed to provide new therapeutic strategies. In recent years, mitophagy, which maintains cell homeostasis, and ferroptosis, a newly discovered cell death mode, have been found to be closely related to IVDD. Importantly, these two processes do not operate in isolation; they interact dynamically through key signaling molecules such as reactive oxygen species (ROS) and pathways including AMPK/mTOR and Nrf2/Keap1, collectively influencing NPC survival and disc integrity. Therefore, we want to propose innovative ideas for IVDD treatment, utilizing the pertinent signaling axes and cytokines as entry sites, by examining the molecular mechanisms of ferroptosis and mitophagy.
    Keywords:  Ferroptosis; Intervertebral disc degeneration; Mitophagy; ROS
    DOI:  https://doi.org/10.1016/j.tice.2025.103227
  34. Life Sci. 2025 Nov 15. pii: S0024-3205(25)00722-2. [Epub ahead of print] 124086
      Parkinson's Disease (PD) is a progressive neurodegenerative disorder marked by dopaminergic neuron degeneration, mitochondrial dysfunction, and Alpha-synuclein (α-synuclein) aggregation. Dynamin-related protein 1 (Drp1), a key regulator of mitochondrial fission, plays a critical role in PD. Overactivation of Drp1 causes excessive mitochondrial fragmentation, impairing mitochondrial function, increasing Reactive oxygen species (ROS) production, and exacerbating oxidative stress, neuroinflammation, and protein misfolding, all of which contribute to PD pathology. Targeting Drp1 with small molecule inhibitors and gene interventions has shown promise in preclinical models by reducing mitochondrial dysfunction, oxidative damage, and neuronal death. Combination therapies, integrating Drp1 inhibitors with antioxidants and anti-inflammatory agents, have demonstrated synergistic effects. Despite promising preclinical findings, clinical studies on Drp1-targeted therapies are still in early stages, with challenges like specificity and off-target effects. Future research will focus on refining Drp1-targeted therapies, including precision medicine, multi-target strategies, and clinical trials to assess efficacy, safety, and pharmacokinetics. This review highlights Drp1 as a promising therapeutic target for PD and discusses future clinical translation challenges.
    DOI:  https://doi.org/10.1016/j.lfs.2025.124086
  35. Apoptosis. 2025 Nov 21.
      Actin gamma 1 (ACTG1) encodes the cytoskeletal protein γ-actin and is overexpressed in various cancers. Cisplatin-based chemotherapy is the standard first-line treatment for patients with advanced non-small cell lung cancer (NSCLC). However, most patients eventually develop cisplatin resistance. The association between ACTG1 and cisplatin resistance remains unclear. In this study, we found that high expression of ACTG1 was associated with poor prognosis in NSCLC. Knockdown of ACTG1 promoted mitochondrial fragmentation via interaction with the fusion protein MFN2 and induced ferroptosis. Mechanistically, ACTG1 knockdown disrupted mitochondrial dynamics, elevated mitochondrial ROS, reduced glutathione (GSH) levels, and enhanced lipid peroxidation. This cascade significantly inhibited the growth of cisplatin-resistant NSCLC cells and sensitized them to cisplatin. Furthermore, the ferroptosis inducer RSL3 synergized with cisplatin to enhance ferroptosis and mitochondrial fragmentation, effectively sensitizing ACTG1-overexpressing cells both in vitro and in xenograft models. Our findings establish ACTG1 as a critical mediator of cisplatin resistance in NSCLC through regulation of mitochondrial integrity and ferroptosis. Targeting the ACTG1-MFN2 axis combined with ferroptosis induction represents a promising therapeutic strategy to overcome cisplatin resistance.
    Keywords:  ACTG1; Cisplatin resistance; Ferroptosis; Mitochondrial fragmentation; NSCLC
    DOI:  https://doi.org/10.1007/s10495-025-02177-y
  36. Sci Rep. 2025 Nov 21. 15(1): 41354
      Human dental pulp stem cells (hDPSCs) senescence impairs their proliferation and osteogenic differentiation, critical for dental stem cell therapy. This study evaluated the effects of Resveratrol on the senescence of hDPSCs to explore new therapeutic strategies. Metabolomic analysis identified age-related metabolic differences in dental pulp tissues, with enriched pathways linked to Resveratrol. In vitro, Resveratrol improved proliferation, delayed senescence, promoted osteogenic differentiation, and enhanced mitochondrial autophagy, function, and biogenesis in senescent hDPSCs, reducing mitochondrial damage and oxidative stress. Mechanistically, silencing PINK1 or PGC-1α reversed Resveratrol-mediated promotion of proliferation, osteogenesis, and senescence suppression. Blocking SIRT1 abrogated its effects on mitochondrial quality control. These findings highlight Resveratrol's potential to mitigate hDPSCs senescence via SIRT1-dependent mitochondrial regulation, offering insights for age-related dental regenerative therapies.
    Keywords:  PINK1 and PGC-1α; Resveratrol; SIRT1; Senescence; hDPSCs
    DOI:  https://doi.org/10.1038/s41598-025-25240-9
  37. Eur J Pharmacol. 2025 Nov 18. pii: S0014-2999(25)01136-7. [Epub ahead of print] 178382
      Lung cancer therapy is constrained by profound intrinsic and acquired resistance to targeted therapies and immunotherapy. To overcome this, a new therapeutic paradigm is emerging that targets the unique metabolic and survival dependencies of cancer cells. Mitochondria, the central hubs of metabolism, cell death, and signaling, represent a critical vulnerability. This review provides a new conceptual framework for understanding and targeting mitochondrial pathways in lung cancer. First, this review outlines the key "mitochondrial hallmarks" of lung cancer that create therapeutic windows, emphasizing the critical role of metabolic heterogeneity. Second, it provides a novel, mechanism-based classification of mitochondrial inhibitors into four major classes: (1) electron transport chain (ETC) inhibitors, (2) metabolic enzyme modulators, (3) apoptosis pathway modulators, and (4) mitochondrial quality control (MQC) disruptors. Third, this review critically analyzes the molecular mechanisms by which these inhibitors activate regulated cell death pathways (apoptosis, ferroptosis) and, most importantly, their potential in overcoming therapeutic resistance to standard-of-care. Fourth, it explores the mechanisms of mitochondrial crosstalk within the tumor microenvironment (TME), including intercellular transfer via tunneling nanotubes. Finally, this review presents a systematic review of the clinical landscape, synthesizing data from preclinical models and ongoing clinical trials. This review concludes by highlighting key limitations and future perspectives, positioning MQC and the mitochondrial unfolded protein response (UPRmt) as next-generation targets to improve patient outcomes.
    Keywords:  Ferroptosis; Lung Cancer; Mitochondria; Mitochondrial Inhibitors; Mitochondrial Quality Control (MQC); Therapeutic Resistance
    DOI:  https://doi.org/10.1016/j.ejphar.2025.178382
  38. bioRxiv. 2025 Oct 02. pii: 2025.10.02.680077. [Epub ahead of print]
      How aging of human neurons affects dynamics of essential organelle such as mitochondria and autophagosomes remains largely unknown. MicroRNA-induced directly reprogrammed neurons (miNs) derived from adult fibroblasts retain age-associated signatures of the donor, enabling the study of age-dependent features in human neurons, including longitudinal isogenic samples. Transcriptomic analysis revealed that neurons derived from elderly individuals are characterized by gene expression changes associated with the regulation of autophagosomes, lysosomes, and mitochondria, compared to young counterparts. To clarify these changes at the cellular level, we performed live-cell imaging of cellular organelles in miNs from donors of different ages. Older donor miNs exhibit decreased mitochondrial membrane potential, which surprisingly co-occurs with a significant increase in mitochondrial fission and fusion events. We posit that the increased fission and fusion of mitochondria may reflect age-dependent compensation for impaired mitochondrial turnover, perhaps due to changes in autophagy. We subsequently identified a significant decrease in autophagosome acidification in neurons derived from individuals >65 years compared to younger donors, and a corresponding age-dependent reduction in neuritic lysosomes resulting in fewer lysosomes available to acidify autophagosomes. This age-dependent deficit in autolysosome flux was rescued by chemically promoting autophagosome generation, which also reversed the age-dependent increase in mitochondrial fission and fusion and improved mitochondrial health. Together, this work reveals a mechanism by which aging reduces autophagic flux secondary to a loss of neuritic lysosomes, resulting in in mitochondria-intrinsic mechanisms to avoid loss of energy production.
    DOI:  https://doi.org/10.1101/2025.10.02.680077
  39. Mater Today Bio. 2025 Dec;35 102459
      Chlorogenic acid (CGA) is widely used to inhibit virus replication and transmission. However, it lacks targeting capabilities and sustained-release properties. In contrast, carbon quantum dots can not only inhibit virus replication directly but can also serve as drug carriers to enhance the targeting capacity and efficacy of antiviral drugs. In this study, CGA carbon dots (CGA-CDs) were prepared using a microwave-assisted synthesis method. The physicochemical characteristics and antiviral activities of CGA-CDs against Newcastle disease virus (NDV) were explored through a series of experiments. The average particle size of CGA-CDs was 5.675 ± 0.15 nm. The CGA-CDs were non-ordered carbon structures composed of C and O, with uniform size, good dispersion properties, and a surface rich in -COOH, -OH, and other hydrophilic groups. The optimal excitation wavelength of CGA-CDs was 390 nm, the emission wavelength was 450 nm, and the CGA-CDs thus emitted blue fluorescence. Notably, CGA-CDs produced significantly stronger antiviral effects than equivalent concentrations of CGA and could successfully inhibit virus adsorption and replication. Furthermore, CGA-CDs significantly inhibited virus-induced mitochondrial dysfunction, mitochondrial autophagy, and mitochondrial antiviral signaling protein (MAVS) degradation, providing superior antiviral efficacy. In vivo experiments further demonstrated the good biocompatibility of CGA-CDs. Moreover, in NDV-infected chickens, CGA-CDs significantly reduced the viral load in the spleen and proventriculus, alleviated pathological damage to major organs, enhanced antibody responses, and markedly lowered the mortality rate. In summary, CGA-CDs showed significant anti-NDV activity by inhibiting NDV adsorption and replication, likely through the inhibition of virus-induced mitophagy and MAVS degradation. These findings highlight the potential of CGA-CDs as potent antiviral agents.
    Keywords:  Antiviral; Carbon quantum dots; Chlorogenic acid; Mitochondrial autophagy
    DOI:  https://doi.org/10.1016/j.mtbio.2025.102459
  40. Mol Biomed. 2025 Nov 21. 6(1): 113
      Colorectal cancer (CRC) is a serious threat to human health, with an approximate 14% mutation rate in the ataxia telangiectasia-mutated (ATM) gene, which is involved in homologous recombination repair. BMN673 (talazoparib), a next-generation poly(ADP-ribose) polymerase (PARP) inhibitor, is the most potent PARP inhibitor (PARPi) reported to date, demonstrating robust anticancer activity. However, the precise mechanism underlying its action in ATM-deficient CRC remains unknown. This study demonstrated that BMN673 stimulated ATM-deficient CRC cell death via a synthetic lethal effect. RNA sequencing analysis revealed significant enrichment of the PERK-ATF4 pathway, mitophagy, and ferroptosis. Functional assays confirmed that BMN673 induced a multifaceted cell death program comprising autophagy-associated death, ferroptosis, and mitophagy, in addition to synthetic lethal. Mechanistically, BMN673 was shown to enhance activating transcription factor 4 (ATF4) transcriptional activity by suppressing poly-ADP-ribosylation (PARylation), facilitating ATF4 binding to the growth differentiation factor 15 (GDF15) promoter region and thereby inducing GDF15 transcriptional expression. Notably, GDF15 overexpression modulated the sensitivity of ATM-deficient CRC cells to BMN673 by promoting autophagy-associated cell death, ferroptosis, and mitophagy, contributing to the anticancer effect of BMN673. Additionally, combining BMN673 with radiotherapy exerted a synergistic anticancer effect on ATM-deficient CRC cells, which was prevented by autophagy inhibition. The findings identified the ATF4-GDF15 pathway as a crucial mediator of BMN673 sensitivity in ATM-deficient CRC cells, revealing therapeutic vulnerability beyond canonical DNA damage repair pathways and providing new insight for combination therapy strategies.
    Keywords:  Colorectal cancer; Ferroptosis; GDF15; Mitophagy; PARP inhibitor BMN673
    DOI:  https://doi.org/10.1186/s43556-025-00356-6
  41. J Hazard Mater. 2025 Nov 14. pii: S0304-3894(25)03418-1. [Epub ahead of print]500 140498
      The rapid expansion of engineered nanoparticle applications has raised critical environmental and health concerns. While traditional toxicological studies have focused primarily on nanoparticle-induced cytotoxicity, they often overlook dynamic cellular defense responses. Here, we elucidate the detoxification strategies employed by macrophages to process MXenes-emerging two-dimensional transition metal carbides and nitrides with exceptional conductivity and biocompatibility but susceptibility to oxidative degradation, revealing a bipartite mechanism that converts material instability into a functional cellular detoxification pathway. Using RAW 264.7 cells, we show that Ti3C2 MXene undergoes accelerated intracellular oxidation compared to cell culture medium, driving its detoxification. This process is mediated by MXene-induced activation of CYP450 enzymes and generation of reactive oxygen species, which collectively metabolize and degrade pristine MXene into less toxic oxidized derivatives, constituting the primary cellular defense mechanism. Residual oxidative damage further triggers mitochondrial depolarization, initiating PINK1/Parkin-dependent mitophagy to eliminate dysfunctional organelles and restore homeostasis. Our findings redefine MXene biological interactions, demonstrating that rapid oxidation is not just a material limitation but a critical detoxification trigger. This paradigm shift provides a new framework for designing safer next-generation 2D materials, though the long-term physiological costs of sustained pathway activation remain a critical area for future investigation.
    Keywords:  CYP450 oxidation; Cellular detoxification; Environmental sustainability; MXene; Mitophagy
    DOI:  https://doi.org/10.1016/j.jhazmat.2025.140498
  42. Gut Microbes. 2025 Dec 31. 17(1): 2580708
      The host EnguLfment and cell MOtility protein 1 (ELMO1) is a cytosolic microbial sensor that binds bacterial effector proteins, including pathogenic effectors from Salmonella (Salmonella enterica serovar Typhimurium) and controls host innate immune signaling. To understand the ELMO1-regulated host pathways, we have performed liquid chromatography Multinotch MS3-Tandem Mass Tag (TMT) multiplexed proteomics to determine the global quantification of proteins regulated by ELMO1 in macrophages during Salmonella infection. Comparative proteome analysis of control and ELMO1-depleted murine J774 macrophages after Salmonella infection quantified more than 7000 proteins with a notable enrichment in mitochondrial-related proteins. Gene ontology enrichment analysis revealed 19 upregulated and 11 downregulated proteins exclusive to ELMO1-depleted cells during infection, belonging to mitochondrial functions, metabolism, vesicle transport, and the immune system. Seahorse analysis showed that Salmonella infection alters mitochondrial metabolism from oxidative phosphorylation to glycolysis-a shift significantly influenced by the depletion of ELMO1. Furthermore, ELMO1 depletion decreased the ATP rate index following Salmonella infection, indicating its importance in counteracting the effects of Salmonella on immunometabolism. Among the proteins involved in mitochondrial pathways, the mitochondrial fission protein DRP1 was significantly upregulated in ELMO1-depleted cells and ELMO1-KO mice intestine following Salmonella infection. Pharmacological inhibition of DRP1 identified the role of ELMO1-DRP1 pathway in the regulation of pro-inflammatory cytokine TNF-α following infection. The role of ELMO1 has been further characterized by a Proteome profiling of ELMO1-depleted macrophage infected with SifA mutant displayed the involvement of ELMO1-SifA in mitochondrial function, metabolism and host immune/defense responses. Collectively, these findings reveal a novel role for ELMO1 in modulating mitochondrial functions, potentially pivotal in modulating inflammatory responses.
    Keywords:  DRP1; ELMO1; Microbial sensor; SifA; bacterial effector; macrophages; mitochondrial dynamics; mitochondrial fission; proteomics
    DOI:  https://doi.org/10.1080/19490976.2025.2580708
  43. Eur J Med Res. 2025 Nov 21. 30(1): 1146
       INTRODUCTION: Mitochondrial unfolded protein response (UPRmt) is implicated in lung adenocarcinoma (LUAD), and our study accordingly aims to establish a model incorporating UPRmt-related genes (MRGs) for predicting the therapeutic response and prognosis in LUAD.
    MATERIALS AND METHODS: The data were sourced from the cancer genome atlas (TCGA) and GSE31210 dataset and MRGs were retrieved to identify those with prognostic relevance, which were applied to recognize the molecular clusters in LUAD. The cluster-specific differentially expressed genes (DEGs) were identified for the functional enrichment analysis. The independent differentially expressed MRGs were sorted out to develop a risk model. Besides, the tumor immune microenvironment was analyzed using the ESTIMATE, TIMER, MCP-counter, and ssGSEA algorithms. The data were processed with Mutect2 to evaluate the genetic mutation landscape, while the IMvigor210 cohort and pRRophetic package were utilized to predict immunotherapeutic responses and drug sensitivity. Finally, in vitro validation was performed via quantitative real-time PCR (qRT-PCR), cell counting kit-8 (CCK-8), wound healing, and Transwell assays.
    RESULTS: Most MRGs were higher expressed in LUAD, and CREB binding protein (CREBBP), lysine demethylase 6B (KDM6B) and leucine rich pentatricopeptide repeat containing (LRPPRC) were the top 3 genes with mutation frequency. 8 MRGs were applied to identify 2 molecular clusters, with the worst prognosis seen in cluster C1. The clusters-specific DEGs were mainly enriched in cell proliferation-related pathways and the established risk model based on 4 hub genes (ANLN, FAM83A, CPS1 and KRT6A) showed satisfying efficacy in predicting the prognosis and was negatively correlated with most immune cells. Besides, the tumor mutation burden tended to be stronger in high risk group with high gene mutation frequency. In IMvigor210 cohort, higher RiskScore was seen in patients with progressive disease and stable disease and related to a worse survival. 3 drug candidates, including Roscovitine, Rapamycin and PHA.665752 were positively correlated with RiskScore. Besides, all 4 MRGs were highly expressed in LUAD cells and the silencing of ANLN repressed the LUAD cell proliferation, migration and invasion.
    DISCUSSION: The established 4-MRGs signature not only serves as a robust prognostic indicator but also highlights the significant involvement of mitochondrial unfolded protein response in shaping tumor microenvironment and influencing immunotherapy outcomes in LUAD.
    CONCLUSION: The 4 MRGs may contribute to the understanding on UPRmt in LUAD and the development of relevant medicine in clinical practice.
    Keywords:   ANLN ; Lung adenocarcinoma; Mitochondrial unfolded protein response; Prognosis; RiskScore; Therapeutic response
    DOI:  https://doi.org/10.1186/s40001-025-03453-y
  44. Respir Med. 2025 Nov 13. pii: S0954-6111(25)00569-4. [Epub ahead of print]250 108506
      Mitochondria are increasingly recognized as central arbiters of cellular fate, placing them at the nexus of pulmonary health and disease. Beyond their canonical role in adenosine triphosphate (ATP) synthesis, these organelles are critical hubs for redox signaling, metabolic homeostasis, and programmed cell death. Mitochondrial dysfunction-a multifaceted condition characterized by impaired bioenergetics, excessive reactive oxygen species (ROS) production, aberrant dynamics, and defective quality control via mitophagy-is a unifying pathogenic feature in chronic lung diseases, including chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF), and pulmonary arterial hypertension (PAH). This dysfunction is also a critical determinant of severity in acute conditions like acute lung injury (ALI) and COVID-19 and is a key mechanistic driver of Long COVID. This review synthesizes the core mechanisms of mitochondrial impairment, delineates their specific contributions to this spectrum of pulmonary pathologies, and discusses the burgeoning field of mitochondria-targeted therapeutics. Strategies ranging from targeted antioxidants and metabolic modulators to novel regenerative approaches like mitochondrial transplantation are highlighted, with an expanded discussion on their limitations, challenges, and clinical implications. By framing mitochondrial integrity as a critical determinant of pulmonary disease, we underscore a pivotal axis for future diagnostic and therapeutic innovation.
    Keywords:  Lung disease; Metabolic reprogramming; Mitochondria; Mitophagy; Oxidative stress
    DOI:  https://doi.org/10.1016/j.rmed.2025.108506
  45. Ecotoxicol Environ Saf. 2025 Nov 14. pii: S0147-6513(25)01751-8. [Epub ahead of print]307 119406
      Short-chain chlorinated paraffins have been classified as persistent organic pollutants (POPs) since 2017. Although previous findings have examined toxicity and health risks of SCCPs, their impacts on germ cells and non-exposed progeny remain unclear. Our results revealed that environmentally relevant concentrations (1 μg/L, 10 μg/L, 100 μg/L and 1000 μg/L) of SCCPs compromised proliferation and maturation of germ cells in parental Caenorhabditis elegans, and exhibited prolonged effects on non-exposed F1 and F2 generations. Whole genome sequencing data suggested the potential impact of SCCPs on genomic stability of germ cells. Transcriptomic analysis showed disrupted expression levels of mitochondrial genes, including many NADH dehydrogenases and mitochondrial genome encoded cytochrome C oxidases in P0 and F1 progeny, which might be associated with increased germ cell apoptosis. The findings highlight long-term impacts of SCCPs on environmental organisms, and suggest possible connections between mitochondrial homeostasis disruption and transgenerational toxicity of SCCPs.
    Keywords:  Germ cell development; Short-chain chlorinated paraffins; Transcriptomic analysis; Transgenerational toxicity; Whole genome sequencing
    DOI:  https://doi.org/10.1016/j.ecoenv.2025.119406
  46. Int J Biol Macromol. 2025 Nov 19. pii: S0141-8130(25)09659-X. [Epub ahead of print] 149102
      Cataracts seriously affect the vision of patients and can even lead to blindness. RAB3GAP2 is associated with cataracts, but its regulatory effects on cataracts need to be determined. We established a mouse model of cataracts and cell models of cataracts induced by NaIO3, to elucidate the exact function and molecular mechanism of RAB3GAP2 in cataract regulation. RAB3GAP2 was highly expressed in the lenses of a mouse model of cataracts. In cell models of cataracts, RAB3GAP2 silencing attenuated apoptosis and reactive oxygen species (ROS) production, intensified mitochondrial autophagy, relieved mitochondrial oxidative stress, and increased the mitochondrial membrane potential. These effects were eliminated by CsA treatment or Mfn2 silencing. We subsequently performed RNA sequencing analysis and experimental verification and found that RAB3GAP2 silencing activated JNK/STAT3 to increase the transcription of Mfn2. Further in vitro studies revealed that SP600125 treatment reversed the effects of RAB3GAP2 silencing on cataract development, the promotion of Mfn2 and mitochondrial autophagy, and the activation and nucleation of STAT3. Finally, in vivo, RAB3GAP2 silencing suppressed apoptosis and ROS production, increased Mfn2 expression and mitochondrial autophagy, and activated JNK/STAT3 and the nucleation of STAT3 in a mouse model of cataracts. However, these in vivo results were abrogated by SP600125 treatment. These findings suggest that RAB3GAP2 silencing can mitigate oxidative stress to prevent cataract development, probably by facilitating Mfn2-mediated mitochondrial autophagy by activating JNK/STAT3. It may be a promising target for treating cataracts.
    Keywords:  Cataract; JNK/STAT3; Mfn2-mediated mitochondrial autophagy; Oxidative stress; RAB3GAP2
    DOI:  https://doi.org/10.1016/j.ijbiomac.2025.149102
  47. Biogerontology. 2025 Nov 18. 27(1): 6
      Aging not only significantly reduces the quality of life for the elderly but also poses multifaceted challenges to society. Its progression involves the synergistic interaction of multidimensional, multipathway molecular mechanisms, including mitochondrial dysfunction, oxidative stress accumulation, chronic inflammation, and genomic damage. Quercetagetin (QG), as a natural flavanol monomer, exhibits significant potential in anti-aging due to its simultaneous targeting of key aging pathways such as oxidative stress and chronic inflammation. We first evaluated QG's safety profile, finding that 0.02 mg/ml QG did not adversely affect motility, feeding, growth, and reproductive capacity in Caenorhabditis elegans (C. elegans). At this concentration, in vivo experiments using wild-type C. elegans confirmed QG's ability to extend lifespan and enhance oxidative stress resistance. The antioxidant and anti-aging effects of QG were further validated using the daf-16 mutant C. elegans DR26. Subsequently, observation of QG's impact on C. elegans mitochondrial morphology revealed significant reductions in area/perimeter and mitochondria coverage ratio following treatment. This indicates that QG treatment shifts the mitochondrial network from fusion toward fission and reduces overall mitochondrial content. QG can also improve age-related dopaminergic, 5-hydroxytryptaminergic and cholinergic neuron degeneration. Mass spectrometry metabolome analysis revealed that QG significantly affected citrate cycle and glycerophospholipid metabolism. Collectively, QG extends C. elegans lifespan by regulating redox homeostasis, DAF-16/FOXO pathways, mitochondrial homeostasis and metabolic reprogramming. This multi-target regulatory capacity positions QG as an ideal candidate molecule for anti-aging drug development.
    Keywords:   C. elegans ; Anti-aging; DAF-16/FOXO pathways; Metabolic reprogramming; Mitochondrial homeostasis; Quercetagetin
    DOI:  https://doi.org/10.1007/s10522-025-10347-3
  48. Transl Psychiatry. 2025 Nov 21. 15(1): 490
      Accumulating evidence suggests that the trace amine-associated receptor 1 (TAAR1) in the medial prefrontal cortex (mPFC) is involved in modulating some areas of behavior related to psychiatric disorders and neurochemical transmission, but the molecular mechanism is unclear. In this study, we used the mPFC transcriptome of TAAR1 knockout mice to investigate the molecular cues associated with TAAR1 and to further explore the potential mechanisms. Following RNA-seq data analysis, several significant protein alterations related to mitochondrial and synaptic function, as well as changes in mitochondrial structure and function, were further verified by a series of experiments including RT-qPCR, Western blot, transmission electron microscopy, and flow cytometry. Mitochondrial dysfunction in the mPFC manifested by decreased mitochondrial membrane potential, increased mitochondrial perimeter, and disturbed fission-fusion dynamics was observed in mice lacking TAAR1. Additionally, synaptic alterations, such as reduced postsynaptic density thickness and decreased expression of postsynaptic-related proteins (p-NR2B, PSD95, and CaMKIIα), suggested impaired synaptic signaling. Behaviorally, TAAR1 knockout mice displayed cognitive deficits, particularly in learning and spatial memory, without significant changes in anxiety- or depressive-like behaviors. Together, these findings suggest that TAAR1 plays a critical role in maintaining mitochondrial and synaptic integrity in the mPFC, and its deficiency may contribute to cognitive impairment, providing novel insights into the mechanisms underlying neuropsychiatric disorders.
    DOI:  https://doi.org/10.1038/s41398-025-03727-3
  49. World J Gastroenterol. 2025 Nov 07. 31(41): 110955
       BACKGROUND: Inflammatory bowel disease (IBD) is a group of chronic, inflammatory disorders that include Crohn's disease and ulcerative colitis. IBD arises from the interaction of various environmental and genetic factors. Altered gut permeability and mitochondrial stress in the colonic mucosa are two mechanisms previously implicated in IBD pathogenesis. We have previously demonstrated activation of the mitochondrial unfolded protein response (UPRmt) in the colonic mucosa of IBD patients and linked this activation to pro-inflammatory signaling. Growth differentiation factor 15 (GDF15) is an important downstream mediator of the UPRmt.
    AIM: To investigate whether GDF15 has a role in IBD and how GDF15 impacts colonic epithelium.
    METHODS: Circulating levels of GDF15 were assessed in plasma samples from IBD patients and healthy controls using an enzyme-linked immunosorbent assay. To study the effects of GDF15 on the colonic mucosa, we employed two different in vitro culture models: Colonic organoids and T84 cells.
    RESULTS: We found that circulating GDF15 Levels were elevated in IBD patients and correlated with markers of inflammation (C-reactive protein) and intestinal permeability [haptoglobin and lipopolysaccharide-binding protein (LBP)]. Additionally, we demonstrated that GDF15 alters the intestinal barrier and increases permeability by decreasing the levels of zonula occludens 1 and claudin 1, critical components of tight junctions. Thus, our findings confirm previous reports of increased circulating GDF15 levels in IBD patients and the activation of UPRmt.
    CONCLUSION: In the present study, we describe a novel mechanism in IBD pathophysiology, linking mitochondrial stress to the disruption of the intestinal barrier and increased intestinal permeability.
    Keywords:  Crohn's disease; Growth differentiation factor 15; Inflammatory bowel disease; Intestinal permeability; Mitochondrial stress; Tight junctions; Ulcerative colitis
    DOI:  https://doi.org/10.3748/wjg.v31.i41.110955
  50. J Nanobiotechnology. 2025 Nov 19. 23(1): 721
      Sarcopenia, a prevalent age-related degenerative disorder, poses significant challenges in geriatric care. Chinese leek demonstrates therapeutic potential against sarcopenia progression, with emerging evidence suggesting its extracellular vesicles (EVs) may mediate these effects. Notably, plant-derived EVs have garnered increasing attention due to their low immunogenicity and capacity for cross-kingdom molecular delivery. This study investigates Chinese leek-derived EVs (CL-EVs) as novel regulators of muscle homeostasis through multi-omics approaches. CL-EVs were isolated via differential ultracentrifugation and characterized using nanoparticle tracking analysis, TEM, and proteomic profiling. Using a dexamethasone (DEX)-induced C2C12 myotube atrophy model, we demonstrated CL-EVs' cellular internalization and dose-dependent restoration of myotube diameter. CL-EVs significantly alleviated DEX-induced mitochondrial impairment in C2C12 cells, evidenced by restored ATP production, reduced ROS levels, and stabilized mitochondrial membrane potential (MMP). Multi-omics analysis revealed CL-EVs activate the AMPK/SIRT1/PGC-1α axis, confirmed by Western blotting. Proteomic analysis identified selenium-associated proteins in CL-EVs. Expanding on selenocompounds' known anti-proteolytic effects through Akt modulation, we demonstrate CL-EVs attenuate myotube atrophy through dual mechanisms: inactivation of Akt/FoxO3a/Atrogin-1/MuRF1 proteolytic signaling and activation of mitochondrial biogenesis/mitophagy pathways, collectively improving muscle homeostasis. To investigate gut-muscle axis interactions, 16 S rDNA sequencing and untargeted metabolomic profiling were performed on fecal samples. CL-EVs treatment attenuated DEX-induced gut microbiota dysbiosis and correlated metabolic abnormalities in sarcopenic mice. This study establishes CL-EVs as novel regulators of muscle homeostasis through dual modulation of AMPK/SIRT1/PGC-1α activation and Akt/FoxO3a/Atrogin-1/MuRF1 inhibition. This innovative "multi-target & gut-muscle axis" paradigm provides a groundbreaking strategy for sarcopenia therapeutics.
    Keywords:  AMPK; Autophagy; Chinese leek; Plant-derived extracellular vesicles; Sarcopenia
    DOI:  https://doi.org/10.1186/s12951-025-03764-6
  51. bioRxiv. 2025 Oct 01. pii: 2025.09.29.679325. [Epub ahead of print]
      Cancer is one of the leading causes of deaths worldwide. Once cancer acquires therapy resistance, it becomes the main driver of cancer lethality in patients. Thus, mechanisms of therapy resistance must be investigated to improve patient outcomes. Mitochondria are critical organelles in the cellular stress responses, undergoing dynamic morphological and functional changes in response to external stimuli. We and others have identified a chemotherapy-resistant cancer cell state where cells that survive treatment exhibit a dramatic increase in cell size and remain non-proliferative for weeks. In this study, we demonstrate that cancer cells that enter this resistant cell state in response to cisplatin increase OMA1 activity and decrease mitochondrial fusion and function to combat oxidative stress. These findings contribute to further understanding the role of the mitochondrial stress responses in therapy resistance in cancer and provide a potential therapeutic avenue to targeting cancer cells that enter this chemotherapy-resistant cell state.
    DOI:  https://doi.org/10.1101/2025.09.29.679325
  52. Toxicology. 2025 Nov 19. pii: S0300-483X(25)00301-4. [Epub ahead of print] 154342
      Fluoride exposure harms human health. Additionally, recent attention has focused on understanding the impact of an adverse in utero environment on the programming of chronic kidney disease in adult offspring. A previous study has described that fluoride alters kidney development, inducing oligonephronia and promoting the premature maturation of remnant nephrons. Therefore, it is essential to continue researching the potential mechanisms involved in fluoride-induced alterations. Female Wistar rats were administered two doses of fluoride (2.5 or 5.0 mg/kg body weight/day) for 20 days before and after mating. The results showed that fluoride diminished catalase and superoxide dismutase activities while increasing the markers of nuclear factor erythroid 2-related factor 2 (Nrf2) activation, mitochondrial dynamics, autophagy, and biogenesis. Morphometric analysis revealed an increase in mitochondrial size and content. Although the levels of Bcl-2-associated X protein (Bax) and B-cell lymphoma 2 (Bcl-2) increased, the activity of caspase-3 and the immunodetection in the TUNEL assay decreased. Several of these changes were mainly observed with the high fluoride dose. In conclusion, the results suggest that fluoride alters the redox status and mitochondrial homeostasis while decreasing apoptosis. It is essential to recognize that, under normal conditions, apoptosis plays a crucial role in proper kidney development, and its occurrence decreases as the structures mature. Therefore, collectively, these alterations could lead to undesirable effects on postnatal life.
    Keywords:  Apoptosis; Autophagy; Fluoride; Kidney; Mitochondrial; Oxidative stress
    DOI:  https://doi.org/10.1016/j.tox.2025.154342
  53. Curr Res Toxicol. 2025 ;9 100263
      Endocrine-disrupting chemicals (EDCs) represent a significant and growing threat to human and animal health, exerting tissue- and concentration-specific effects on endocrine function. This study investigated the acute impact of bisphenol A (BPA) on nuclear receptor signaling and mitochondrial dynamics in hypothalamic AgRP-NPY (agouti-related peptide; neuropeptide Y) and POMC (pro-opiomelanocortin) neurons. Mice received a single intraperitoneal injection of BPA at doses of 40  µg/kg, 5  mg/kg, or 10  mg/kg, and were assessed 6 h post-exposure. Quantitative analysis of hypothalamic mRNA expression revealed that low-dose BPA (40  µg/kg) didn't affect ERα (estrogen receptor alpha), TRα (thyroid receptor alpha), but significantly upregulated PPARγ (peroxisome proliferator-activated receptor gamma). Concurrently, mitochondrial respiration and ultrastructure exhibited dose-dependent alterations, with diminished effects observed at higher BPA concentrations. These findings demonstrate that BPA elicits rapid, dose-dependent modulation of nuclear receptor gene expression and mitochondrial dynamics in hypothalamic neurons. The data suggest mitochondria serve as early subcellular targets of EDC exposure. This underscores the importance of evaluating low-dose EDC effects to improve risk assessment and regulatory frameworks.
    Keywords:  Endocrine disruptor; Melanocortin system; Mitochondrial morphology; Mitochondrial respiration; Nuclear hormone receptor
    DOI:  https://doi.org/10.1016/j.crtox.2025.100263
  54. Brain Res. 2025 Nov 18. pii: S0006-8993(25)00603-1. [Epub ahead of print] 150040
      Alzheimer's disease (AD) is a multiplex and progressive neurodegenerative disorder commonly recognized by the accumulation of amyloid-β (Aβ) plaques, neurofibrillary tangles (NFTs), and dysfunction in the cholinergic and glutamatergic systems. At the early stages of AD, mitochondrion operates as a neuroprotective organelle in both neuronal and glial cells by compensating energy fluctuations. As the disease progresses, mitochondrial function in both neurons and glial cells deteriorates, culminating in impaired cellular metabolism and glial hyperactivation. This time-dependent hyperactivation of microglia and astrocytes sequentially promotes the release of pro-inflammatory cytokines, elevates reactive oxygen species, disrupts calcium homeostasis, and increases oxidative stress. Altogether, these processes drive neuroinflammation, which both influences and is influenced by mitochondrial activity. Additionally, mitochondrial dysfunction across the disease trajectory hampers communication between neurons and glial cells, promoting excitotoxicity in neurons. This review emphasizes the vital role of mitochondrial dynamics in AD pathophysiology across different stages and explores how cell-specific targeting of mitochondrial activity could mitigate neuroinflammation, restore neuronal function, and offer potential treatment benefits. Enhancing mitochondrial function in healthy neurons and glial cells, particularly in microglia as a compensatory mechanism, especially at the early stage of the disease or restoring mitochondrial function of surviving neurons at the later stages, may promote neuroprotection and improve neuron-glia interactions, thus offering a potential strategy for AD treatment.
    Keywords:  Alzheimer’s disease; Glial cells; Mitochondrial dynamics; Neuroinflammation
    DOI:  https://doi.org/10.1016/j.brainres.2025.150040
  55. ACS Pharmacol Transl Sci. 2025 Nov 14. 8(11): 4159-4171
      Metastatic evolution of malignant tumors following standard anticancer therapies and the emergence of resistant cancer cell populations remain major challenges in oncology. One promising strategy is to develop compounds that selectively target mechanisms of therapeutic resistance. Unlike therapy-sensitive malignant cells, which rely primarily on glycolysis for energy, many chemoresistant cells and cancer stem cells (CSCs) preferentially utilize mitochondrial oxidative phosphorylation (OXPHOS). In this study, we employed a triple-negative breast cancer model to demonstrate that short antimicrobial peptides can significantly suppress the metastatic potential of resistant cancer cells and reduce the formation of CSC-like mammospheres by disrupting mitochondrial respiration. This effect was further enhanced by conjugating the peptides to the mitochondrial-targeting cation triphenylphosphonium (TPP). Mechanistic studies revealed that these compounds induce oxidative stress and mitophagy and suppress mitochondrial translation. Collectively, these findings suggest that TPP-conjugated peptides represent a promising therapeutic strategy for targeting OXPHOS-dependent resistance in aggressive solid tumors.
    Keywords:  antimicrobial peptides; cancer resistance; cancer stem cells; mitochondria; mitophagy; oxidative phosphorylation
    DOI:  https://doi.org/10.1021/acsptsci.5c00563
  56. Invest Ophthalmol Vis Sci. 2025 Nov 03. 66(14): 40
       Purpose: Endoplasmic reticulum (ER) stress participates in the development of various disorders by regulating tissue remodeling and apoptosis. This study aimed to explore the regulatory role of mitofusin 2 (Mfn2)-mediated ER stability in scleral remodeling in myopia.
    Methods: Myopia was induced in rats by form deprivation and hyperopic defocus. Scleral remodeling, ER stress, oxidative stress, and Mfn2 protein expression were examined in vivo. ER and mitochondrial ultrastructure were assessed by electron microscopy, and tissue apoptosis was evaluated. Primary rat scleral fibroblasts (SFs) were exposed to hypoxia to establish an in vitro myopia model, and Mfn2 expression in SFs was interfered by cell transfection. The extent of SFs transdifferentiation, extracellular-matrix remodeling, ER stress, mitochondrial damage, and cell apoptosis were assessed.
    Results: In this study, we discovered that tissue remodeling was accompanied by ER stress and oxidative stress in the sclera of myopic rats. Concomitantly, Mfn2 expression levels were significantly decreased, and the structures of the ER and mitochondria were damaged, along with tissue apoptosis. In vitro study showed that both hypoxia induction and MFN2 knockdown significantly increased hypoxia-inducible factor-1α expression in SFs. Mfn2 overexpression inhibited the transdifferentiation of hypoxia-induced SFs into myofibroblasts and upregulated the expression of collagen Iα1. Additionally, Mfn2 overexpression alleviated ER stress and mitochondrial damage in hypoxia-induced SFs, and reduced apoptosis of SFs.
    Conclusions: Our study revealed a critical role of Mfn2 in maintaining ER homeostasis in SFs, which conferred protective effects during scleral remodeling and provided a new therapeutic target for myopia.
    DOI:  https://doi.org/10.1167/iovs.66.14.40
  57. Cancer Lett. 2025 Nov 13. pii: S0304-3835(25)00704-9. [Epub ahead of print]637 218132
      Oncogenic KRAS causes the immunosuppressive tumor microenvironment (TME) to decrease the therapeutic response to radiotherapy (RT) and is associated with poor outcomes. In this study, we observed that constitutive dynamin-related protein 1 (DRP1) phosphorylation by oncogenic KRAS resulted in a decrease in mitochondrial DNA (mtDNA) content, leading to attenuated radiotherapy-induced cGAS/STING-driven type I IFN secretion. Targeting DRP1 phosphorylation enhanced cytosolic mtDNA release to promote cGAS/STING activation in response to radiotherapy. Disruption of cGAS-STING signaling limited the immune-enhancing effect of DRP1 targeting on type I IFN production and T-cell killing ability. Targeting DRP1 increased the therapeutic response and induced systemic antitumor immunity, accompanied by increased type I IFN signaling and intratumoral infiltration of immune cells in response to radiotherapy. Notably, the immune-enhancing effects of DRP1 inhibition were impaired by IFN receptor blockade. Moreover, dual targeting of DRP1 and MEK significantly enhanced the therapeutic response to RT in a KRASG12D-driven CRC model, providing its clinical relevance to target undruggable KRASG12D-driven CRC patients. Taken together, these findings reveal that DRP1 phosphorylation-mediated mtDNA decrease is a suppressor of antitumor immunity, suggesting that targeting DRP1 could be used to increase tumor immunogenicity and improve responsiveness to radiotherapy, especially in oncogenic KRAS-driven CRC patients.
    Keywords:  DRP1; KRAS; MEK; Neoadjuvant chemoradiotherapy; STING
    DOI:  https://doi.org/10.1016/j.canlet.2025.218132
  58. bioRxiv. 2025 Oct 04. pii: 2025.10.02.680066. [Epub ahead of print]
      Myogenic commitment is a decisive and irreversible step in skeletal muscle regeneration, necessitating proliferating myoblasts to integrate metabolic cues with nuclear transcriptional programs. Among amino acids, glutamine is uniquely positioned to influence this transition by coupling energy production to macromolecule biosynthesis and epigenetic regulation. We reasoned that myoblasts must sense glutamine availability to ensure orderly progression toward commitment, and we tested this by examining the molecular consequences of acute glutamine withdrawal. We find that continued glutamine oxidation is required to sustain glycolysis, maintain mitochondrial fission, and preserve a redox balance that supports progression towards myogenic commitment. In its absence, myoblasts undergo a reductive shift, characterized by mitochondrial elongation, membrane depolarization, and suppression of glycolysis, ultimately leading to growth arrest. Transcriptomic profiling reveals reduced MyoD and MKi67 , accompanied by increased Sprouty1 levels, defining a reversible non-proliferative state that resembles but is distinct from quiescent and reserve cells. We term this state Poised Metabolic Arrest (PMA), a cellular response to glutamine limitation during myogenic progression. Mechanistically, PMA is driven by Nrf2-dependent increased glutathione (GSH) biosynthesis and upregulation of mitochondrial GSH carrier Slc25a39 when glutamine is limited. Depleting mitochondrial glutathione or silencing Slc25a39 forces exit from PMA. However, this premature exit compromises subsequent differentiation potential, indicating PMA serves to preserve differentiation competence when glutamine is limited. Consistent with this, both loss and overexpression of Slc25a39 impair myoblast differentiation in vitro and disrupt regeneration in vivo. Together, these data suggest that a reciprocal Slc25a39-Nrf2 redox axis functions as a nutrient-dependent checkpoint, coupling glutamine availability to mitochondrial remodeling and metabolic reprogramming, necessary to establish irreversible myogenic commitment.
    DOI:  https://doi.org/10.1101/2025.10.02.680066
  59. J Biochem. 2025 Nov 21. pii: mvaf073. [Epub ahead of print]
      Autophagy is a conserved degradation process delivering intracellular components to lysosomes or vacuoles. Yeast studies have been pivotal in identifying autophagy-related (ATG) genes and defining the core machinery essential for autophagosome formation. A recent comprehensive analysis that systematically examined all atg mutants in S. cerevisiae under autophagy-inducing conditions revealed that mutants lacking Atg13, Atg8-conjugation, or Atg12-conjugation components retain partial activity in certain autophagy-related pathways, indicating that these core factors are not strictly essential for autophagy in yeast. In this commentary, we summarize how recent findings reshape our understanding of the flexibility in the essentiality of core autophagy factors and discuss the emerging importance of protein interaction-driven feedback in autophagy regulation.
    Keywords:  Atg8; Autophagy; Lysosome; Mitophagy; Vacuole
    DOI:  https://doi.org/10.1093/jb/mvaf073
  60. bioRxiv. 2025 Oct 05. pii: 2025.10.04.680452. [Epub ahead of print]
      The ATP-driven mHsp60:mHsp10 chaperonin system assists protein folding within the mitochondrial matrix of human cells. Substrate protein folding has been proposed to occur through interconnected single- and double-ring pathways. In the absence of nucleotide, mHsp60 exists in equilibrium between free protomers and heptameric single rings, while the formation of double rings requires ATP. Here, we present cryo-electron microscopy structures of mHsp60 in the apo state, bound to ATP, and bound to ATP in complex with the cochaperonin mHsp10. ATP binding to single-ring apo mHsp60 7 triggers coordinated conformational changes in the intermediate and apical domains, resulting in a highly dynamic apical region within the ring. Extensive inter-subunit rearrangements flatten the equatorial surface of each ring, thereby enabling inter-ring contacts that stitch the rings together to form double-ring mHsp60 14 . Collectively, these structures define the structural basis of ATP-driven double-ring assembly of a human mitochondrial chaperonin responsible for maintaining mitochondrial protein homeostasis.
    DOI:  https://doi.org/10.1101/2025.10.04.680452